amiodarone has been researched along with Thyroid Diseases in 156 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Thyroid Diseases: Pathological processes involving the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate the impact of 8weeks of amiodarone treatment on thyroid function in patients with atrial fibrillation (AF) undergoing catheter ablation in a randomised, double-blind clinical trial." | 9.22 | Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: Results from the placebo-controlled, randomized AMIO-CAT trial. ( Chen, X; Darkner, S; Diederichsen, SZ; Feldt-Rasmussen, U; Hansen, J; Johannesen, A; Pehrson, S; Svendsen, JH, 2016) |
| "We compared the efficacy and safety of amiodarone and dronedarone in patients with persistent atrial fibrillation (AF)." | 9.14 | A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. ( Davy, JM; De Ferrari, GM; Le Heuzey, JY; Radzik, D; Santini, M; Zhu, J, 2010) |
| "This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 9.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 7.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "Amiodarone may induce hyper- or hypothyroidism." | 7.70 | High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment. ( Balestrieri, A; Lai, ME; Loviselli, A; Mandas, A; Mariotti, S; Martino, E; Murenu, S; Sau, F; Vacquer, S; Valentino, L, 1999) |
| "Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 7.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
| "A rare case of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with nonthyroidal illness is reported." | 7.67 | Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness. ( Balestrieri, A; Balzano, S; Bartalena, L; Cherchi, A; Martino, E; Ruscazio, M; Sau, F, 1987) |
| "Amiodarone, an iodine-rich drug widely used for the treatment of cardiac tachyarrhythmias, may induce either hyperthyroidism or hypothyroidism." | 7.67 | Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ( Aghini-Lombardi, F; Bambini, G; Bartalena, L; Braverman, LE; Ceccarelli, C; Lenziardi, M; Mariotti, S; Martino, E; Pinchera, A; Safran, M, 1987) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 7.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "Iodide-induced hypothyroidism has also been observed in patients with a history of postpartum thyroiditis, in euthyroid patients after a previous episode of subacute thyroiditis, and in patients treated with recombinant interferon-alpha who developed transient thyroid dysfunction during interferon-a treatment." | 6.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
| "Iodine induced hyperthyroidism is frequently observed in patients affected by euthyroid iodine deficient goiter when suddenly exposed to excess iodine." | 6.41 | Iodine excess and hyperthyroidism. ( Roti, E; Uberti, ED, 2001) |
| " A dose-response relationship was observed between the 1-year accumulated amiodarone dose and the subsequent 5-year cumulative incidence of thyroid dysfunction." | 5.91 | Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. ( Ali, SA; Butt, JH; Ersbøll, M; Fosbøl, E; Gustafsson, F; Jøns, C; Kristensen, SL; Køber, L; Mogensen, UM; Rørth, R; Selmer, C; Vinding, NE; Weeke, PE; Westergaard, LM, 2023) |
| " These data show that iodine released by amiodarone has a bioavailability different from that of NaI." | 5.28 | Changes in 127I mice thyroid follicle studied by analytical ion microscopy: a key for the comprehension of amiodarone-induced thyroid diseases. ( Briançon, C; Fragu, P; Halpern, S; Telenczak, P, 1990) |
| "Amiodarone, a drug that has electrophysiologic actions resembling those of hypothyroidism, increases serum levels of T4 and reverse T3 (rT3) and decreases T3." | 5.27 | Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias. ( Callahan, B; Hendrickson, JA; Hershman, JM; Nademanee, K; Singh, BN, 1986) |
| "We aimed to evaluate the impact of 8weeks of amiodarone treatment on thyroid function in patients with atrial fibrillation (AF) undergoing catheter ablation in a randomised, double-blind clinical trial." | 5.22 | Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: Results from the placebo-controlled, randomized AMIO-CAT trial. ( Chen, X; Darkner, S; Diederichsen, SZ; Feldt-Rasmussen, U; Hansen, J; Johannesen, A; Pehrson, S; Svendsen, JH, 2016) |
| "In SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial), which randomized patients with ischemic or nonischemic HF to placebo or amiodarone or implantable cardioverter-defibrillator therapy, thyroid-stimulating hormone (TSH) was measured at baseline and at 6-month intervals throughout the 5-year study." | 5.17 | Thyroid function in heart failure and impact on mortality. ( Anderson, J; Bardy, GH; Hellkamp, AS; Johnson, GW; Lee, KL; Mark, DB; Mitchell, JE; Poole, JE, 2013) |
| "We compared the efficacy and safety of amiodarone and dronedarone in patients with persistent atrial fibrillation (AF)." | 5.14 | A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. ( Davy, JM; De Ferrari, GM; Le Heuzey, JY; Radzik, D; Santini, M; Zhu, J, 2010) |
| "This is a substudy of a prospective randomized controlled trial (SAFE-Trial) in which amiodarone, sotalol, and placebo for persistent atrial fibrillation were evaluated." | 5.12 | Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation. ( Batcher, EL; Hershman, JM; Reda, DJ; Singh, BN; Singh, SN; Tang, XC, 2007) |
| "Thyroid disorders and eye diseases are interrelated through several mechanisms thus, awareness of this relation has a great impact on early diagnosis and treatment." | 5.05 | Thyroid and Eye: Where They Meet in Clinical Practice. ( El-Eshmawy, MM; Shahin, M, 2020) |
| "Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation." | 4.88 | Mechanisms in endocrinology: Heart failure and thyroid dysfunction. ( Biondi, B, 2012) |
| "To summarize the mechanisms of iodine-induced hypothyroidism and hyperthyroidism, identify the risk factors for thyroid dysfunction following an iodine load, and summarize the major sources of excess iodine exposure." | 4.88 | Iodine-induced thyroid dysfunction. ( Braverman, LE; Leung, AM, 2012) |
| " More recently, it has been suggested that rhTSH is useful for treatment of multinodular goiter and amiodarone-induced thyrotoxicosis, as well as for diagnosis of congenital hypothyroidism." | 4.84 | Recombinant human thyrotropin in the management of thyroid disorders. ( Graf, H; Paz-Filho, GJ, 2008) |
| " Treatment with amiodarone may lead to changes in thyroid tests results and to development of hypothyroidism or thyrotoxicosis." | 4.82 | [Thyroid and cardiovascular disorders]. ( Gajek, J; Zyśko, D, 2004) |
| "Amiodarone, an anti-ischaemic and anti-arrhythmic drug, has been the object of numerous studies and seems to be highly effective in the treatment of severe ventricular arrhythmias on dilated cardiomyopathies, as well as of hypertrophic or ischaemic heart diseases." | 4.78 | [Does amiodarone have a benefit effect on mortality?]. ( Kahn, JC; Pathé, M, 1991) |
| " An increase of the thyroid iodine content (TIC) is observed in all patients at the exception of those who develop hypothyroidism under treatment." | 4.77 | [Thyroid function and amiodarone. Consequences on dysthyroidism testing]. ( Fragu, P; Schlumberger, M, 1985) |
| " Ultrasound has a role in the investigation of Graves' disease, subacute thyroiditis, gestational thyrotoxicosis, postpartum thyroiditis, amiodarone thyrotoxicosis and goiter with or without adenoma, but adenomas are usually investigated by endocrine surgeons in Sweden." | 4.12 | [Thyroid ultrasound and its role in the investigation of thyroid disease]. ( Almquist, M; Koutouridou, E; Lantz, M; Mijovic, Z; Pellby, D; Planck, T; Tsoumani, K, 2022) |
| "Amiodarone is used in patients with arrhythmias, but thyroid dysfunction [amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH)] is a common adverse effect." | 3.91 | The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients. ( Barrett, B; Bauer, AJ; Hawkes, CP; Isaza, A, 2019) |
| " This study was intended to determine whether CRP levels could differentiate between inflammatory and noninflammatory thyroid conditions, especially between type II inflammatory amiodarone-induced thyrotoxicosis (AIT) and type I iodine-induced AIT." | 3.72 | The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. ( Bogazzi, F; Braverman, LE; Brogioni, S; Lazarus, JH; Martino, E; Pardini, E; Parkes, AB; Pearce, EN; Pellegrini, G; Pinchera, A, 2003) |
| "During 1 year of amiodarone intake development of amiodarone-associated thyroid dysfunction was observed in 25% of patients (hypothyroidism and thyrotoxicosis in 19." | 3.72 | [Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction]. ( Bakalov, SA; Golitsin, SP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Soboleva, VA; Sviridenko, NIu, 2004) |
| "In 232 Japanese patients receiving long-term amiodarone therapy for life-threatening ventricular tachyarrhythmias, hyperthyroidism and hypothyroidism developed in 29 patients (12." | 3.71 | Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. ( Hagiwara, N; Kasanuki, H; Matsuda, N; Sato, K; Shiga, T; Shoda, M; Wakaumi, M, 2001) |
| "Amiodarone may induce hyper- or hypothyroidism." | 3.70 | High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment. ( Balestrieri, A; Lai, ME; Loviselli, A; Mandas, A; Mariotti, S; Martino, E; Murenu, S; Sau, F; Vacquer, S; Valentino, L, 1999) |
| "Because little has been published on early effects of treatment with amiodarone on thyroid function, we studied serum total and free thyroid hormone, reverse T3, and TSH levels in patients with cardiac arrhythmias during the first 10 days of treatment with a loading dose of amiodarone by iv infusion." | 3.69 | Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. ( Berti, S; Biagini, A; Bonini, R; Carpi, A; Chopra, IJ; Clerico, A; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M, 1997) |
| "Plasma iodine was below 40 micrograms/l in 57 (7%) patients, most of whom had hypothyroidism; 40-80 micrograms/l in 439 (55%) patients, most of whom had normal thyroid hormone function; 80-250 micrograms/l in 240 (30%) patients, most of whom had hyperthyroidism; and above 250 micrograms/l in 63 (8%) patients, almost all of whom had iodine overload caused by iodinated drugs, particularly amiodarone, resulting in euthyroidism (24%), hyperthyroidism (36%), and hypothyroidism (16%)." | 3.68 | Use of plasma iodine assay for diagnosing thyroid disorders. ( Allain, P; Barbot, N; Berre, S; Bigorgne, JC; Krari, N; Lainé-Cessac, P; Le Bouil, A; Rohmer, V, 1993) |
| "To assess the incidence of adverse effects associated with long-term amiodarone therapy, we reviewed the records of 217 consecutive patients who were treated for refractory arrhythmia." | 3.67 | Side effects and complications of amiodarone therapy. ( Lown, B; Podrid, PJ; Raeder, EA, 1985) |
| "A rare case of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with nonthyroidal illness is reported." | 3.67 | Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness. ( Balestrieri, A; Balzano, S; Bartalena, L; Cherchi, A; Martino, E; Ruscazio, M; Sau, F, 1987) |
| "Amiodarone, an iodine-rich drug widely used for the treatment of cardiac tachyarrhythmias, may induce either hyperthyroidism or hypothyroidism." | 3.67 | Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ( Aghini-Lombardi, F; Bambini, G; Bartalena, L; Braverman, LE; Ceccarelli, C; Lenziardi, M; Mariotti, S; Martino, E; Pinchera, A; Safran, M, 1987) |
| "In the face of the recent introduction of beta-blockers and calcium inhibitors, the author examines the role of Amiodarone, Perhexiline and Molsidomine in the treatment of angina pectoris." | 3.66 | [The classic anti-anginal agents and molsidomine]. ( Vacheron, A, 1983) |
| " Both, hypo- and hyperthyroidism can occur, probably as a result of the iodine overload on a preexisting thyroid disorder." | 3.66 | Amiodarone and the thyroid gland. A review. ( Jonckheer, MH, 1981) |
| "Amiodarone was administered to 154 patients who had sustained, symptomatic ventricular tachycardia (VT) (n = 118) or a cardiac arrest (n = 36) and who were refractory to conventional antiarrhythmic drugs." | 3.66 | Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. ( Bhandari, A; Keung, E; Malone, P; Morady, F; Sauve, MJ; Scheinman, MM; Schwartz, AB; Shen, EN; Sung, RJ, 1983) |
| "This study suggests that Tc-99m sestamibi may be an alternative tracer for thyroid scintigraphy and uptake measurement of patients on chronic use of amiodarone." | 2.75 | Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging. ( Amorim, BJ; Camargo, EE; de Almeida, EA; de Oliveira Santos, A; Etchebehere, EC; Guariento, MH; Lima, MC; Oki, GC; Ramos, CD; Tambascia, MA; Zantut-Wittmann, DE, 2010) |
| "Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a structure similar to that of thyroid hormones." | 2.72 | Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders. ( Burman, KD; Wartofsky, L; Ylli, D, 2021) |
| "Amiodarone was searched using the terms adverse effects, hypothyroidism, myxedema, hyperthyroidism, thyroid storm, atrial fibrillation, ventricular arrhythmia, and electrical storm." | 2.61 | Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. ( Bianco, AC; McAninch, EA; Sharma, PS; Trohman, RG, 2019) |
| "Amiodarone is an antiarrhythmic drug frequently used in everyday clinical practice." | 2.53 | [Clinical procedure in amiodarone-induced thyroid dysfunction]. ( Cygankiewicz, I; Kosmalski, M; Michalak, R; Ptaszyński, P; Różycka-Kosmalska, M; Wranicz, JK; Zieleniewski, W, 2016) |
| "Amiodarone is an effective anti-arrhythmic agent for control of various life threatening ventricular tachyarrhythmias but may give Various side effects." | 2.48 | Amiodarone therapy: don't forget thyroid. ( Fatima, N; Sajjad, Z, 2012) |
| "Dronedarone was approved in 2009 for the treatment of patients with atrial fibrillation." | 2.46 | Effects of amiodarone therapy on thyroid function. ( Cohen-Lehman, J; Dahl, P; Danzi, S; Klein, I, 2010) |
| "Triiodothyronine (T3) has no role in the treatment of primary hypothyroidism." | 2.45 | Management of thyroid disorders in primary care: challenges and controversies. ( Todd, CH, 2009) |
| "Dronedarone appears to be an alternative but less-effective anti-arrhythmic agent and it does not have adverse effects on thyroid function." | 2.45 | Benzofuran derivatives and the thyroid. ( Han, TS; Vanderpump, MP; Williams, GR, 2009) |
| "Amiodarone is a frequently used antiarrhythmic drug with a high antiarrhythmic potency." | 2.44 | [Thyroid and treatment with amiodarone diagnosis, therapy and clinical management]. ( Mikosch, P, 2008) |
| "Hypothyroidism is a well defined clinical situation managable thanks to common guidelines." | 2.42 | [Amiodarone and thyroid dysfunction: a pending problem]. ( Perazza, L; Scardi, S, 2003) |
| " Here, we discuss safety issues relating to the long-term use of oral amiodarone in adults." | 2.42 | Using oral amiodarone safely. ( , 2003) |
| "Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease." | 2.41 | The effects of amiodarone on the thyroid. ( Bartalena, L; Bogazzi, F; Braverman, LE; Martino, E, 2001) |
| "Iodine induced hyperthyroidism is frequently observed in patients affected by euthyroid iodine deficient goiter when suddenly exposed to excess iodine." | 2.41 | Iodine excess and hyperthyroidism. ( Roti, E; Uberti, ED, 2001) |
| "Iodide-induced hypothyroidism has also been observed in patients with a history of postpartum thyroiditis, in euthyroid patients after a previous episode of subacute thyroiditis, and in patients treated with recombinant interferon-alpha who developed transient thyroid dysfunction during interferon-a treatment." | 2.41 | Iodine-Induced hypothyroidism. ( Georgopoulos, N; Kyriazopoulou, V; Markou, K; Vagenakis, AG, 2001) |
| "Amiodarone is a highly effective antiarrhythmic agent." | 2.40 | [Follow-up of patients treated by amiodarone]. ( Kulbertus, H; Lancellotti, P; Mélon, P, 1998) |
| "Aggravation of cardiac arrhythmias occurs but serious arrhythmias are caused in less than 5% of patients." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| " A dose-response relationship was observed between the 1-year accumulated amiodarone dose and the subsequent 5-year cumulative incidence of thyroid dysfunction." | 1.91 | Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study. ( Ali, SA; Butt, JH; Ersbøll, M; Fosbøl, E; Gustafsson, F; Jøns, C; Kristensen, SL; Køber, L; Mogensen, UM; Rørth, R; Selmer, C; Vinding, NE; Weeke, PE; Westergaard, LM, 2023) |
| "Amiodarone is a widely used anti-arrythmic drug with considerable potential to cause thyroid dysfunction because of its 35% iodine content." | 1.33 | [The effects of amiodaron on the thyroid function]. ( Kucharczyk, A; Kucharczyk, P; Michałkiewicz, D, 2006) |
| "Noncardiovascular adverse effects associated with amiodarone result in substantial morbidity." | 1.29 | Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone. ( Follin, SL; Ordelova, A; Tisdale, JE; Webb, CR, 1995) |
| " These data show that iodine released by amiodarone has a bioavailability different from that of NaI." | 1.28 | Changes in 127I mice thyroid follicle studied by analytical ion microscopy: a key for the comprehension of amiodarone-induced thyroid diseases. ( Briançon, C; Fragu, P; Halpern, S; Telenczak, P, 1990) |
| "Hypothyroidism was diagnosed in 11 patients (12%), and a further 11 had tests consistent with a "failing thyroid." | 1.27 | Effect of amiodarone on thyroid hormone economy. ( Glick, S; Posner, J; Sobel, RJ, 1984) |
| "Hyperthyroidism was a more frequent (9." | 1.27 | Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. ( Aghini-Lombardi, F; Aronin, N; Fay, M; Haffajee, C; Lenziardi, M; Macchia, E; Martino, E; Pacchiarotti, A; Rajatanavin, R; Safran, M, 1984) |
| "Amiodarone is a very active antiarrhythmic agent, but true incidence of Amiodarone-related side effects is still questionable." | 1.27 | Side effects during therapy with low dosage amiodarone. ( Beck Peccoz, P; Ferrario, G; Galletti, F; Giani, P; Landolina, M; Maggioni, AP; Piscitelli, G; Tognoni, G; Volpi, A, 1984) |
| "Amiodarone, a drug that has electrophysiologic actions resembling those of hypothyroidism, increases serum levels of T4 and reverse T3 (rT3) and decreases T3." | 1.27 | Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias. ( Callahan, B; Hendrickson, JA; Hershman, JM; Nademanee, K; Singh, BN, 1986) |
| "A physiological dose of iodine is necessary for thyroid hormonogenesis, but in pharmacological dosage it is a danger." | 1.26 | [Iatrogenic thyroid pathology]. ( Léger, AF; Savoie, JC, 1977) |
| "Amiodarone is a drug which is frequently used in cardiology, and which can lead to the appearance of hyper- of hypo-thyroidism in certain cases." | 1.26 | [Amiodarone and thyroid function]. ( Bernard, R; Blockx, P; Broeckaert, I; Jonckheer, MH, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 61 (39.10) | 18.7374 |
| 1990's | 29 (18.59) | 18.2507 |
| 2000's | 33 (21.15) | 29.6817 |
| 2010's | 26 (16.67) | 24.3611 |
| 2020's | 7 (4.49) | 2.80 |
| Authors | Studies |
|---|---|
| Lantz, M | 1 |
| Almquist, M | 1 |
| Koutouridou, E | 1 |
| Pellby, D | 1 |
| Planck, T | 1 |
| Tsoumani, K | 1 |
| Mijovic, Z | 1 |
| Ali, SA | 2 |
| Ersbøll, M | 2 |
| Vinding, NE | 2 |
| Butt, JH | 2 |
| Rørth, R | 2 |
| Selmer, C | 2 |
| Westergaard, LM | 2 |
| Mogensen, UM | 2 |
| Weeke, PE | 2 |
| Jøns, C | 2 |
| Gustafsson, F | 2 |
| Fosbøl, E | 2 |
| Køber, L | 2 |
| Kristensen, SL | 2 |
| Kupnovytska, I | 1 |
| Virstiuk, N | 1 |
| Danyliuk, O | 1 |
| Luchko, O | 1 |
| Kocherzhat, O | 1 |
| Goundan, PN | 1 |
| Lee, SL | 1 |
| Ylli, D | 2 |
| Wartofsky, L | 3 |
| Burman, KD | 4 |
| Sukor, N | 1 |
| Lachumanan, D | 1 |
| Kamaruddin, NA | 1 |
| Elnaggar, MN | 1 |
| Jbeili, K | 1 |
| Nik-Hussin, N | 1 |
| Kozhippally, M | 1 |
| Pappachan, JM | 1 |
| Trohman, RG | 1 |
| Sharma, PS | 1 |
| McAninch, EA | 1 |
| Bianco, AC | 1 |
| Tisdale, JE | 2 |
| El-Eshmawy, MM | 1 |
| Shahin, M | 1 |
| Barrett, B | 1 |
| Hawkes, CP | 1 |
| Isaza, A | 1 |
| Bauer, AJ | 1 |
| Mitchell, JE | 1 |
| Hellkamp, AS | 1 |
| Mark, DB | 1 |
| Anderson, J | 1 |
| Johnson, GW | 1 |
| Poole, JE | 1 |
| Lee, KL | 1 |
| Bardy, GH | 1 |
| Lakatos, P | 1 |
| Austin, PC | 1 |
| Park-Wyllie, LY | 1 |
| Juurlink, DN | 1 |
| Klein, I | 2 |
| Danzi, S | 2 |
| Różycka-Kosmalska, M | 1 |
| Michalak, R | 1 |
| Kosmalski, M | 1 |
| Ptaszyński, P | 1 |
| Wranicz, JK | 1 |
| Zieleniewski, W | 1 |
| Cygankiewicz, I | 1 |
| Diederichsen, SZ | 1 |
| Darkner, S | 1 |
| Chen, X | 1 |
| Johannesen, A | 1 |
| Pehrson, S | 1 |
| Hansen, J | 1 |
| Feldt-Rasmussen, U | 1 |
| Svendsen, JH | 1 |
| Huang, CJ | 1 |
| Tseng, CL | 1 |
| Chu, CH | 1 |
| Huang, DF | 1 |
| Huang, CC | 1 |
| Lin, LY | 1 |
| Rankin, S | 1 |
| Elder, DH | 1 |
| Ogston, S | 1 |
| George, J | 1 |
| Lang, CC | 1 |
| Choy, AM | 1 |
| Han, TS | 1 |
| Williams, GR | 1 |
| Vanderpump, MP | 1 |
| Piga, M | 1 |
| Serra, A | 1 |
| Boi, F | 1 |
| Tanda, ML | 2 |
| Martino, E | 11 |
| Mariotti, S | 3 |
| Paz-Filho, GJ | 1 |
| Graf, H | 1 |
| Kim, DD | 1 |
| Young, S | 1 |
| Cutfield, R | 1 |
| Kimura, H | 1 |
| Kato, Y | 1 |
| Shimizu, S | 1 |
| Takano, K | 1 |
| Sato, K | 2 |
| Cohen-Lehman, J | 1 |
| Dahl, P | 1 |
| Todd, CH | 1 |
| Oki, GC | 1 |
| Zantut-Wittmann, DE | 1 |
| de Oliveira Santos, A | 1 |
| Guariento, MH | 1 |
| Tambascia, MA | 1 |
| de Almeida, EA | 1 |
| Amorim, BJ | 1 |
| Lima, MC | 1 |
| Etchebehere, EC | 1 |
| Camargo, EE | 1 |
| Ramos, CD | 1 |
| Le Heuzey, JY | 1 |
| De Ferrari, GM | 1 |
| Radzik, D | 1 |
| Santini, M | 1 |
| Zhu, J | 1 |
| Davy, JM | 1 |
| Thomas, Z | 1 |
| Bandali, F | 1 |
| McCowen, K | 1 |
| Malhotra, A | 1 |
| Barbesino, G | 1 |
| Lee, KF | 1 |
| Lee, KM | 1 |
| Fung, TT | 1 |
| Tsadok, MA | 1 |
| Jackevicius, CA | 1 |
| Rahme, E | 1 |
| Essebag, V | 1 |
| Eisenberg, MJ | 1 |
| Humphries, KH | 1 |
| Tu, JV | 1 |
| Behlouli, H | 1 |
| Joo, J | 1 |
| Pilote, L | 1 |
| Kesselheim, AS | 1 |
| Fatima, N | 1 |
| Sajjad, Z | 1 |
| Leung, AM | 1 |
| Braverman, LE | 8 |
| Biondi, B | 1 |
| Martin, CM | 1 |
| Nishikawa, M | 1 |
| Toyoda, N | 1 |
| Nomura, E | 1 |
| Siccama, R | 1 |
| Balk, AH | 1 |
| de Herder, WW | 1 |
| van Domburg, R | 1 |
| Vantrimpont, P | 1 |
| van Gelder, T | 1 |
| Pearce, EN | 1 |
| Bogazzi, F | 4 |
| Brogioni, S | 2 |
| Pardini, E | 1 |
| Pellegrini, G | 1 |
| Parkes, AB | 1 |
| Lazarus, JH | 1 |
| Pinchera, A | 3 |
| Mel'nichenko, GA | 2 |
| Sviridenko, NIu | 4 |
| Molashenko, NV | 4 |
| Platonova, NM | 4 |
| Aleksandrova, GF | 1 |
| Egorov, AV | 2 |
| Perazza, L | 1 |
| Scardi, S | 1 |
| de Paola, AV | 1 |
| Cirenza, C | 1 |
| Maciel, RM | 1 |
| Fuks, AG | 1 |
| Vaisman, M | 1 |
| Buescu, A | 1 |
| Serdiuk, SE | 2 |
| Bakalov, SA | 2 |
| Soboleva, VA | 1 |
| Golitsin, SP | 1 |
| Zyśko, D | 1 |
| Gajek, J | 1 |
| Golitsyn, SP | 1 |
| Dedov, II | 1 |
| Schmidt-Ott, UM | 1 |
| Ascheim, DD | 1 |
| Kucharczyk, P | 1 |
| Michałkiewicz, D | 1 |
| Kucharczyk, A | 1 |
| Kurnik, D | 1 |
| Loebstein, R | 1 |
| Olchovsky, D | 1 |
| Goldschlager, N | 1 |
| Epstein, AE | 1 |
| Naccarelli, GV | 1 |
| Olshansky, B | 1 |
| Singh, B | 1 |
| Collard, HR | 1 |
| Murphy, E | 1 |
| Batcher, EL | 1 |
| Tang, XC | 1 |
| Singh, BN | 2 |
| Singh, SN | 1 |
| Reda, DJ | 1 |
| Hershman, JM | 2 |
| Mikosch, P | 1 |
| Blank, W | 1 |
| Braun, B | 1 |
| Borst, GC | 1 |
| Eil, C | 1 |
| Lubbe, WF | 1 |
| Mercer, CJ | 1 |
| Harris, L | 1 |
| McKenna, WJ | 1 |
| Rowland, E | 1 |
| Holt, DW | 1 |
| Storey, GC | 1 |
| Krikler, DM | 1 |
| Friocourt, P | 1 |
| Coumel, P | 2 |
| Zipes, DP | 1 |
| Prystowsky, EN | 1 |
| Heger, JJ | 1 |
| Rajatanavin, R | 2 |
| Vacheron, A | 1 |
| Posner, J | 1 |
| Sobel, RJ | 1 |
| Glick, S | 1 |
| Safran, M | 3 |
| Aghini-Lombardi, F | 5 |
| Lenziardi, M | 2 |
| Fay, M | 1 |
| Pacchiarotti, A | 1 |
| Aronin, N | 1 |
| Macchia, E | 1 |
| Haffajee, C | 1 |
| Landolina, M | 1 |
| Beck Peccoz, P | 1 |
| Piscitelli, G | 1 |
| Maggioni, AP | 1 |
| Volpi, A | 1 |
| Galletti, F | 1 |
| Tognoni, G | 1 |
| Ferrario, G | 1 |
| Giani, P | 1 |
| Eason, RJ | 1 |
| Croxson, MS | 1 |
| Lim, TM | 1 |
| Evans, MC | 1 |
| Cooper, GJ | 1 |
| Morady, F | 1 |
| Sauve, MJ | 1 |
| Malone, P | 1 |
| Shen, EN | 1 |
| Schwartz, AB | 1 |
| Bhandari, A | 1 |
| Keung, E | 1 |
| Sung, RJ | 1 |
| Scheinman, MM | 1 |
| Fidelle, J | 1 |
| Do-Ngoc, D | 1 |
| Attuel, P | 1 |
| Jonckheer, MH | 3 |
| Larsen, PR | 2 |
| Lambert, M | 1 |
| Burger, A | 1 |
| Coche, E | 1 |
| Ferrero, C | 1 |
| Kulbertus, HE | 1 |
| Demoulin, JC | 1 |
| Bertholet, M | 1 |
| Jaggarao, NS | 1 |
| Sheldon, J | 1 |
| Grundy, EN | 1 |
| Vincent, R | 1 |
| Chamberlain, DA | 1 |
| Paulus, WJ | 1 |
| Ranquin, R | 1 |
| Parizel, G | 1 |
| Ahmad, S | 1 |
| Follin, SL | 1 |
| Ordelova, A | 1 |
| Webb, CR | 1 |
| Shukla, R | 1 |
| Jowett, NI | 1 |
| Thompson, DR | 1 |
| Pohl, JE | 1 |
| Nyström, E | 1 |
| Lindstedt, G | 1 |
| Tisell, LE | 1 |
| Berg, G | 1 |
| Edvardsson, N | 1 |
| Walfridsson, H | 1 |
| Adlerberth, A | 1 |
| Wemeau, JL | 3 |
| Bauters, C | 1 |
| Coviaux, R | 1 |
| Anouilh, A | 1 |
| Maillez, T | 1 |
| D'herbomez, M | 1 |
| Devemy, F | 1 |
| Decoulx, M | 2 |
| Schlienger, JL | 1 |
| Kaltenbach, G | 1 |
| Offner, M | 1 |
| Sapin, R | 1 |
| Gasser, G | 1 |
| Roul, G | 1 |
| Allain, P | 1 |
| Berre, S | 1 |
| Krari, N | 1 |
| Lainé-Cessac, P | 1 |
| Le Bouil, A | 1 |
| Barbot, N | 1 |
| Rohmer, V | 1 |
| Bigorgne, JC | 1 |
| Gittoes, NJ | 1 |
| Franklyn, JA | 4 |
| Wenzel, KW | 1 |
| Leenhardt, L | 1 |
| Banerjee, S | 1 |
| James, CB | 1 |
| Iervasi, G | 1 |
| Clerico, A | 1 |
| Bonini, R | 1 |
| Manfredi, C | 1 |
| Berti, S | 1 |
| Ravani, M | 1 |
| Palmieri, C | 1 |
| Carpi, A | 1 |
| Biagini, A | 1 |
| Chopra, IJ | 1 |
| Harjai, KJ | 1 |
| Licata, AA | 1 |
| Bartalena, L | 7 |
| Manetti, L | 1 |
| Wiersinga, WM | 3 |
| Pitsiavas, V | 1 |
| Smerdely, P | 1 |
| Li, M | 1 |
| Boyages, SC | 1 |
| Lancellotti, P | 1 |
| Mélon, P | 1 |
| Kulbertus, H | 1 |
| Modlinska, A | 1 |
| Sworczak, K | 1 |
| Loviselli, A | 2 |
| Murenu, S | 1 |
| Sau, F | 2 |
| Valentino, L | 1 |
| Mandas, A | 1 |
| Vacquer, S | 1 |
| Balestrieri, A | 2 |
| Lai, ME | 1 |
| Thorne, SA | 1 |
| Barnes, I | 1 |
| Cullinan, P | 1 |
| Somerville, J | 1 |
| Loh, KC | 1 |
| Erdoğan, MF | 1 |
| Güleç, S | 1 |
| Tutar, E | 1 |
| Güldal, M | 1 |
| Başkal, N | 1 |
| Erdoğan, G | 1 |
| Roti, E | 1 |
| Uberti, ED | 1 |
| Markou, K | 1 |
| Georgopoulos, N | 1 |
| Kyriazopoulou, V | 1 |
| Vagenakis, AG | 1 |
| Gasperi, M | 1 |
| Shiga, T | 1 |
| Wakaumi, M | 1 |
| Matsuda, N | 1 |
| Shoda, M | 1 |
| Hagiwara, N | 1 |
| Kasanuki, H | 1 |
| Jeantet, M | 1 |
| Losay, J | 1 |
| Cassinat, G | 1 |
| Andral, J | 1 |
| Guize, L | 1 |
| de Pouvourville, G | 1 |
| Savoie, JC | 1 |
| Léger, AF | 1 |
| Blockx, P | 2 |
| Broeckaert, I | 2 |
| Cornette, C | 1 |
| Beckers, C | 1 |
| Bernard, R | 1 |
| Gasińska, T | 1 |
| Mandecki, T | 1 |
| Szydło, E | 1 |
| Szulc, A | 1 |
| Nowakowska, M | 1 |
| Machado, HB | 1 |
| da Silva, ME | 1 |
| Pinho, B | 1 |
| Gómez, JM | 1 |
| Virgili, N | 1 |
| Montaña, E | 1 |
| Gausi, C | 1 |
| Soler, J | 1 |
| Pathé, M | 1 |
| Kahn, JC | 1 |
| Widerhorn, J | 1 |
| Bhandari, AK | 1 |
| Bughi, S | 1 |
| Rahimtoola, SH | 1 |
| Elkayam, U | 1 |
| Chow, CC | 1 |
| Cockram, CS | 1 |
| Briançon, C | 1 |
| Halpern, S | 1 |
| Telenczak, P | 1 |
| Fragu, P | 2 |
| De Rosa, G | 1 |
| Corsello, SM | 1 |
| Testa, A | 1 |
| Callà, C | 1 |
| Simonin, R | 1 |
| Kennedy, RL | 1 |
| Griffiths, H | 1 |
| Gray, TA | 1 |
| Málek, Z | 1 |
| Dorociaková, E | 1 |
| Kojsová, M | 1 |
| Willems, AR | 1 |
| Schöttelndreiër, MA | 1 |
| Manouvrier, J | 1 |
| Cappoen, JP | 1 |
| Caron, C | 1 |
| Ducloux, G | 1 |
| Laurent, M | 1 |
| Edan, G | 1 |
| Massart, C | 1 |
| Biron, Y | 1 |
| Le Helloco, A | 1 |
| Druelles, P | 1 |
| Costa, C | 1 |
| Visalli, N | 1 |
| Natoli, A | 1 |
| Monteiro, E | 1 |
| Galvão-teles, A | 1 |
| Santos, ML | 1 |
| Mourão, L | 1 |
| Correia, MJ | 1 |
| Lopo Tuna, J | 1 |
| Ribeiro, C | 1 |
| Endert, E | 1 |
| Trip, MD | 2 |
| Verhaest-de Jong, N | 1 |
| Gammage, MD | 3 |
| Balzano, S | 3 |
| Raeder, EA | 1 |
| Podrid, PJ | 1 |
| Lown, B | 1 |
| Pichler, WJ | 1 |
| Schindler, L | 1 |
| Stäubli, M | 1 |
| Stadler, BM | 1 |
| de Weck, AL | 1 |
| Weetman, AP | 1 |
| Bhandal, SK | 1 |
| Burrin, JM | 1 |
| Robinson, K | 1 |
| McKenna, W | 1 |
| Sica, V | 1 |
| Pilosu, R | 1 |
| Petrini, L | 1 |
| Giannessi, G | 1 |
| Buratti, L | 1 |
| Ruscazio, M | 1 |
| Cherchi, A | 1 |
| Rabinowe, SL | 1 |
| Antman, EM | 1 |
| George, KL | 1 |
| Friedman, PL | 1 |
| Jackson, RA | 1 |
| Eisenbarth, GS | 1 |
| Depelchin, P | 1 |
| Schoenfeld, P | 1 |
| Stoupel, E | 1 |
| Degré, S | 1 |
| Disertori, M | 1 |
| Inama, G | 1 |
| Rey, E | 1 |
| Bachrach, LK | 1 |
| Burrow, GN | 1 |
| Weissel, M | 1 |
| Weber, H | 1 |
| Ceccarelli, C | 1 |
| Bambini, G | 1 |
| Logan, SD | 1 |
| Nademanee, K | 1 |
| Callahan, B | 1 |
| Hendrickson, JA | 1 |
| Gómez-Balaguer, M | 1 |
| Caballero Calabuig, E | 1 |
| Gilsanz Peral, A | 1 |
| Costa Talens, P | 1 |
| Abalovich, MS | 1 |
| Gutiérrez, S | 1 |
| Aszenmil, G | 1 |
| Guitelman, A | 1 |
| Mechlis, S | 1 |
| Lubin, E | 1 |
| Laor, J | 1 |
| Margaliot, M | 1 |
| Strasberg, B | 1 |
| Valenzuela, MA | 2 |
| Bianchi, C | 2 |
| Pineda, G | 3 |
| Meruane, J | 2 |
| Schlumberger, M | 1 |
| Popiliev, I | 1 |
| Alves, LE | 1 |
| Rose, EP | 1 |
| Cahill, TB | 1 |
| Sanmartí, A | 1 |
| Permanyer, G | 1 |
| Foresti, V | 1 |
| Parisio, E | 1 |
| Scolari, N | 1 |
| Carini, L | 1 |
| Lovagnini-Scher, CA | 1 |
| Unger, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Hypothyroidism After the TAVI Procedure in Elderly Patients[NCT04831957] | 20 participants (Anticipated) | Interventional | 2021-07-26 | Recruiting | |||
| First-line Cryoablation for Early Treatment of Persistent Atrial Fibrillation - a Randomized Study Comparing Early Trigger Isolation Using the Cryoballoon Versus Antiarrhythmic Medication[NCT05939076] | Phase 3 | 220 participants (Anticipated) | Interventional | 2023-08-21 | Not yet recruiting | ||
| Randomized Double Blind Trial to Evaluate the Efficacy and Safety of Dronedarone (400mg BID) Versus Amiodarone (600mg Daily for 28 Days, Then 200mg Daily Thereafter) for at Least 6 Months for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrill[NCT00489736] | Phase 3 | 504 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
| Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation[NCT05130268] | Phase 4 | 3,000 participants (Anticipated) | Interventional | 2021-10-29 | Active, not recruiting | ||
| Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes: a 2-years Prospective Multicentric Study[NCT04298684] | Phase 4 | 90 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | ||
| Telemedicine Enabling Patients in Self-care Behaviors[NCT04297735] | 60 participants (Actual) | Interventional | 2020-02-26 | Completed | |||
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"The considered event is the occurrence of the MSE defined as thyroid, hepatic, pulmonary, neurological, skin, eye, or gastrointestinal specific treatment emergent events or premature study drug discontinuation following any adverse event (AE), whichever comes first. The analysis is performed on the time from first study drug intake to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period." (NCT00489736)
Timeframe: minimum study duration is 6 months (+10 days); maximum is 15 months
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 83 |
| Amiodarone 600mg/200mg od | 107 |
"The considered event is the occurrence of the MSE excluding gastrointestinal specific treatment emergent events defined as diarrhoea, nausea, vomiting. The analysis is performed on the time from first study drug intake to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period." (NCT00489736)
Timeframe: minimum study duration is 6 months (+10 days); maximum is 15 months
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 61 |
| Amiodarone 600mg/200mg od | 99 |
"The primary event is the treatment failure defined as the first recurrence of atrial fibrillation or premature study drug discontinuation for intolerance or lack of efficacy according to the investigator judgement. The primary efficacy analysis is performed on the time from first study drug intake to this primary event. The Measured Values table below presents the numbers of patients with the event at the end of the study period." (NCT00489736)
Timeframe: minimum study duration is 6 months (+10 days); maximum is 15 months
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 184 |
| Amiodarone 600mg/200mg od | 141 |
52 reviews available for amiodarone and Thyroid Diseases
| Article | Year |
|---|---|
Thyroid effects of amiodarone: clinical update.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Drug Monitoring; Humans; Incidence; Prevalence; Th | 2020 |
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.
Topics: Albania; Amiodarone; Arrhythmias, Cardiac; Coronary Artery Disease; Humans; Male; Middle Aged; Myoca | 2021 |
Amiodarone-Induced Thyroid Dysfunction: A Clinical Update.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chest Pain; Coronary Artery Disease; Humans; Male; Middle Aged; | 2018 |
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Humans; Predictive Value of Tests; Prognosis; Risk Asse | 2019 |
Thyroid and Eye: Where They Meet in Clinical Practice.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antithyroid Agents; Diabetic Retinopathy; Eye; Eye Dise | 2020 |
Thyroid Disease and the Heart.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Heart Diseases; Hemodynamics; Humans; Hydroxymethylglut | 2016 |
[Clinical procedure in amiodarone-induced thyroid dysfunction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Risk Factors; Thyroid Diseases; Thyroid | 2016 |
Benzofuran derivatives and the thyroid.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzofurans; Dronedarone; Humans; Hypothyroidism; Recep | 2009 |
Amiodarone-induced thyrotoxicosis. A review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Interleukin-6; Iodine; Iodine Radioisotopes; Iopanoic Ac | 2008 |
Recombinant human thyrotropin in the management of thyroid disorders.
Topics: Amiodarone; Clinical Trials as Topic; Goiter; Humans; Iodine Radioisotopes; Neoplasm Metastasis; Rec | 2008 |
Effects of amiodarone therapy on thyroid function.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Dronedarone; Humans; Hypothyroidism; Iodine; Thyroid Di | 2010 |
Management of thyroid disorders in primary care: challenges and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Primary Health Care; Thyroid Diseases; Triiodothyronine | 2009 |
Drug-induced endocrine disorders in the intensive care unit.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antifungal Agents; Antimanic Agents; Critical Care; Cytochrome P | 2010 |
Drugs affecting thyroid function.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Drug Interactions; Drug Monitorin | 2010 |
Amiodarone therapy: don't forget thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Thyroid Diseases; Thyroid Hormones | 2012 |
Iodine-induced thyroid dysfunction.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Dietary Supplements; | 2012 |
Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; | 2012 |
[Drug-induced thyroid dysfunction].
Topics: Amiodarone; Humans; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland; Thyroid Hormones | 2012 |
Using oral amiodarone safely.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Eruptions; Drug | 2003 |
[Amiodarone-induced thyroid dysfunction (pathogenesis, diagnosis, treatment)].
Topics: Amiodarone; Humans; Iodide Peroxidase; Receptors, Thyroid Hormone; Thyroid Diseases; Thyrotropin | 2003 |
[Amiodarone and thyroid dysfunction: a pending problem].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Diseases | 2003 |
[Thyroid and cardiovascular disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Coronary Artery B | 2004 |
Thyroid hormone and heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Failure; Humans; Thyroid Diseases; Thyroxine; Triiodothyro | 2006 |
[Thyroid and treatment with amiodarone diagnosis, therapy and clinical management].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Follow-Up Studies; Humans; Hyperthyr | 2008 |
Euthyroid hyperthyroxinemia.
Topics: Amiodarone; Amphetamines; Blood Protein Disorders; Female; Humans; Ipodate; Male; Mental Disorders; | 1983 |
[Side effects of amiodarone].
Topics: Amiodarone; Benzofurans; Brain Diseases; Cardiovascular Diseases; Eye Diseases; Humans; Skin Disease | 1983 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Euthyroid hyperthyroxinemia.
Topics: Amiodarone; Autoantibodies; Dextroamphetamine; Heparin; Humans; Propranolol; Serum Albumin; Thyroglo | 1983 |
Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones.
Topics: Adolescent; Amiodarone; Animals; Brain; Cholecystography; Feedback; Female; Graves Disease; Humans; | 1982 |
Drug-induced thyroid disorders.
Topics: Amiodarone; Drug-Related Side Effects and Adverse Reactions; Humans; Iodine; Lithium; Thyroid Diseas | 1995 |
Disturbances of thyroid function tests by drugs.
Topics: Amiodarone; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Humans; Predic | 1996 |
Amiodarone-induced dysthyroidism. Pitfalls and management.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Monitoring; Female; Humans; Male; Thyroid Diseases; Thyroid | 1995 |
Effects of amiodarone on thyroid function.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart; Humans; Thyroid Diseases; Thyroid Function Tests; Thyroid | 1997 |
[Follow-up of patients treated by amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Contraindications; Drug Interactions; Drug Monitoring; Follow-Up | 1998 |
[Amiodarone and the thyroid gland].
Topics: Amiodarone; Animals; Dose-Response Relationship, Drug; Humans; Thyroid Diseases; Thyroid Gland; Thyr | 1998 |
Amiodarone-induced thyroid disorders: a clinical review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Thyroid Diseases | 2000 |
HLA-B40-, HLA-Cw3-, and HLA-DR5-associated susceptibility to amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Anti-Arrhythmia Agents; HLA Antigens; HLA-B Antigens; HLA-B40 Antigen; HLA-C Antigens; H | 2000 |
The effects of amiodarone on the thyroid.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Female; Hormone Replacement Therapy; Humans; | 2001 |
Iodine excess and hyperthyroidism.
Topics: Amiodarone; Endemic Diseases; Environmental Exposure; Goiter; Graves Disease; Hyperthyroidism; Iodin | 2001 |
Iodine-Induced hypothyroidism.
Topics: Amiodarone; Drug Synergism; Female; Goiter; Humans; Hypothyroidism; Infant, Newborn; Iodides; Iodine | 2001 |
The various effects of amiodarone on thyroid function.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Male; Pregnancy; Thyroid Diseases; Thyroid Gland; Thyrot | 2001 |
Iodine effects on the thyroid gland: biochemical and clinical aspects.
Topics: Amiodarone; Autoimmune Diseases; Contrast Media; Humans; Hyperthyroidism; Iodides; Iodine; Iodine Ra | 2000 |
[Does amiodarone have a benefit effect on mortality?].
Topics: Amiodarone; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Eye Diseases; France; Heart Arrest; Humans | 1991 |
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infan | 1991 |
Thyroid disorders induced by lithium and amiodarone: an overview.
Topics: Amiodarone; Animals; Goiter; Humans; Hypothyroidism; Lithium; Thyroid Diseases; Thyroid Hormones; Th | 1990 |
[Amiodarone-induced thyroid pathology].
Topics: Amiodarone; Antithyroid Agents; Female; Humans; Hyperthyroidism; Hypothyroidism; Lithium; Male; Midd | 1987 |
Amiodarone and the thyroid.
Topics: Amiodarone; Disease Susceptibility; Humans; Thyroid Diseases; Thyroid Hormones | 1989 |
[Amiodarone and its side effects].
Topics: Amiodarone; Chemical and Drug Induced Liver Injury; Corneal Diseases; Humans; Lung Diseases; Periphe | 1988 |
Amiodarone and the thyroid.
Topics: Amiodarone; Heart; Heart Diseases; Humans; Thyroid Diseases; Thyroid Gland; Thyroid Hormones | 1987 |
[Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; H | 1986 |
[Thyroid function and amiodarone. Consequences on dysthyroidism testing].
Topics: Amiodarone; Animals; Benzofurans; Biotransformation; Humans; Hyperthyroidism; Hypothyroidism; Iodine | 1985 |
[Amiodarone: pharmacology, clinical use and side effects].
Topics: Amiodarone; Arrhythmias, Cardiac; Autonomic Nervous System; Benzofurans; Blood Coagulation; Digitali | 1985 |
7 trials available for amiodarone and Thyroid Diseases
| Article | Year |
|---|---|
Thyroid function in heart failure and impact on mortality.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Female; Heart Failure; Humans | 2013 |
Short-term amiodarone treatment for atrial fibrillation after catheter ablation induces a transient thyroid dysfunction: Results from the placebo-controlled, randomized AMIO-CAT trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Denmark; Double-Bl | 2016 |
Tc-99m sestamibi thyroid imaging in patients on chronic amiodarone treatment: a comparison with Tc-99m pertechnetate imaging.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Female; Humans; | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Dronedarone; Ele | 2010 |
Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Female; Humans; Hyper | 2007 |
Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.
Topics: Adult; Aged; Amiodarone; Antibody Formation; Autoantibodies; Autoimmune Diseases; Benzofurans; Doubl | 1986 |
[Extracardiac side effects of Aminodarone].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Clinical Trials as Topic; Drug Evaluation; Eye Diseas | 1986 |
97 other studies available for amiodarone and Thyroid Diseases
| Article | Year |
|---|---|
[Thyroid ultrasound and its role in the investigation of thyroid disease].
Topics: Amiodarone; Female; Graves Disease; Humans; Thyroid Diseases; Thyrotoxicosis | 2022 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Heart Failure; Humans; Hypothyroidism; Incidence | 2023 |
[HEPATOCELLULAR TOXICITY IN THE BACKGROUND OF AMIODARON-INDUCED THYROID DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Hum | 2019 |
Letter to the Editor from Sukor et al: "Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders".
Topics: Amiodarone; Humans; Thyroid Diseases | 2021 |
Response to Letter to the Editor from Sukor et al.: "Evaluation and Treatment of Amiodarone-induced Thyroid Disorders".
Topics: Amiodarone; Humans; Thyroid Diseases | 2021 |
Editorial commentary: Amiodarone-induced thyroid diseases: Additional unintended consequences.
Topics: Amiodarone; Humans; Thyroid Diseases | 2019 |
The Effects of Amiodarone on Thyroid Function in Pediatric and Young Adult Patients.
Topics: Adolescent; Amiodarone; Arrhythmias, Cardiac; Child; Child, Preschool; Female; Humans; Incidence; In | 2019 |
[Editor's commentary. Advances in endocrinology].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diabetic Neuropathies; Endocrine System Diseases; Female; Humans | 2013 |
Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Cohort Studies; Diphosphonates; Epid | 2014 |
Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction.
Topics: Age Factors; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Guideline Adherenc | 2017 |
Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; | 2017 |
A survey of thyroid function test abnormalities in patients presenting with atrial fibrillation and flutter to a New Zealand district hospital.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flut | 2008 |
Association of polymorphism at position 49 in exon 1 of the cytotoxic T-lymphocyte-associated factor 4 gene with Graves' disease refractory to medical treatment, but not with amiodarone-associated thyroid dysfunction.
Topics: Adult; Amiodarone; Antigens, CD; CTLA-4 Antigen; Female; Graves Disease; Humans; Male; Middle Aged; | 2009 |
Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; China; Female; Humans; Hypothyro | 2010 |
Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; | 2011 |
The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drugs, Generic; Female; Humans; Male; Thyro | 2011 |
Thyroid dysfunction and the elderly patient: a primer for pharmacists.
Topics: Aged; Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Pharmacists; Thyroid Diseases; Thyroid Gl | 2012 |
Amiodarone therapy before heart transplantation as a predictor of thyroid dysfunction after transplantation.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cohort Studies; Female; Heart Transpla | 2003 |
The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Case-Control Studie | 2003 |
[The cardiologist should suspect more thyroid dysfunction!].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Heart Diseases; Humans; Male; Risk Factors; Thyroid Dise | 2004 |
Thyroid dysfunction and cardiological management in patients receiving amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Brazil; Female; Heart Diseases; Humans; Male; Middle Aged; Preva | 2004 |
[Amiodarone-associated thyroid dysfunction: prevalence and possibilities of correction].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Antithyroid Agents; Data Interpretatio | 2004 |
[Incidence and predictors of thyroid dysfunction caused by long-term intake of amiodaron].
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Hypothyroidism; Inci | 2005 |
[Diagnostics, treatment, and prevention of iatrogenic iodine-induced thyroid gland diseases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Follow-Up Studies; Humans; Iatroge | 2006 |
[The effects of amiodaron on the thyroid function].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Disease | 2006 |
Amiodarone for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Humans; International Norma | 2007 |
A practical guide for clinicians who treat patients with amiodarone: 2007.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Interactions; Female; Humans; Lung Diseases; Male; Tachycar | 2007 |
[Sonography of the thyroid--part 2: thyroid inflammation, impairmant of thyroid function and interventions].
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Chronic Disease; Female; Humans; Hyperthyroidism; | 2008 |
Amiodarone: its side effects, adverse reactions and dosage schedules.
Topics: Amiodarone; Benzofurans; Central Nervous System Diseases; Drug Administration Schedule; Eye Diseases | 1982 |
Side effects of long-term amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Dose-Response Relation | 1983 |
[The classic anti-anginal agents and molsidomine].
Topics: Amiodarone; Angina Pectoris; Angina Pectoris, Variant; Humans; Kinetics; Molsidomine; Oxadiazoles; P | 1983 |
Effect of amiodarone on thyroid hormone economy.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Hyperthyroidism; Hypothy | 1984 |
Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Goiter; Heart Diseases; Humans; Hyperthyroidism; Hypot | 1984 |
Side effects during therapy with low dosage amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Female; Humans; Male; | 1984 |
Goitre and thyroid dysfunction during chronic amiodarone treatment.
Topics: Adult; Amiodarone; Benzofurans; Female; Goiter; Humans; Male; Thyroid Diseases; Thyroid Function Tes | 1984 |
Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
Topics: Aged; Amiodarone; Anorexia; Ataxia; Benzofurans; Female; Heart Arrest; Humans; Lung Diseases; Male; | 1983 |
[Amiodarone in the treatment of cardiac rhythm disturbances in children. Apropos of 135 cases].
Topics: Administration, Oral; Adolescent; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Child, Presc | 1980 |
Amiodarone and the thyroid gland. A review.
Topics: Amiodarone; Animals; Benzofurans; Dogs; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Dis | 1981 |
[Modifications and surveillance of thyroid tests during treatment with amiodarone].
Topics: Amiodarone; Benzofurans; Humans; Thyroid Diseases; Thyroid Function Tests | 1982 |
[Amiodarone: review of its antianginal properties and analysis of side effects].
Topics: Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Corneal Diseases; Coronary Vessels; | 1982 |
The effects of amiodarone on thyroid function.
Topics: Adult; Aged; Amiodarone; Benzofurans; Humans; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyroxin | 1982 |
Systolic time intervals: a valuable parameter of thyroid function.
Topics: Adult; Amiodarone; Female; Humans; Hyperthyroidism; Male; Myocardial Contraction; Systole; Thyroid D | 1980 |
Treatment guidelines for hyperthyroidism and hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Practice Guidelines as Topic; Thyro | 1995 |
Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone.
Topics: Adult; Age Factors; Aged; Amiodarone; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; | 1995 |
Side effects with amiodarone therapy.
Topics: Aged; Amiodarone; Drug Administration Schedule; Drug Eruptions; Female; Humans; Male; Middle Aged; N | 1994 |
[Amiodarone--a warning! Clarify possible thyroid disease before treatment!].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Thyroid Diseases; Thyroid Function Tests; Thyroid Gland | 1994 |
[Thyroid dysfunctions related to amiodarone. Prospective survey with 116 patients].
Topics: Aged; Aged, 80 and over; Amiodarone; Female; Humans; Male; Middle Aged; Prospective Studies; Thyroid | 1993 |
[Increase of free fatty acids under the effect of amiodarone].
Topics: Amiodarone; Fatty Acids, Nonesterified; Humans; Reference Values; Thyroid Diseases; Thyroid Hormones | 1994 |
Use of plasma iodine assay for diagnosing thyroid disorders.
Topics: Adult; Aged; Amiodarone; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Ma | 1993 |
Amiodarone and dysthyroid eye disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Eye Diseases; Humans; Male; Thyroid Diseases | 1996 |
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Kinetics; Male; Middle Aged; Thyroid Disease | 1997 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Hypothyroidism; Thyroid Diseases; Thyroid Gland; Thyroto | 1995 |
Towards an animal model of amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Thyroid Diseases; Thyroid Gland | 1997 |
Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB/W rat and the Wistar rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Cell Nucleus; Endoplasmic Reticulum; Inclusi | 1997 |
High prevalence of thyroid dysfunction in adult patients with beta-thalassemia major submitted to amiodarone treatment.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; beta-Thalassemia; Female; Humans; Hypothyroidism; Male; T | 1999 |
Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Case-Control Studies; Female; Heart Defects, | 1999 |
[Iatrogenic thyroid disorders].
Topics: Amiodarone; Anti-Arrhythmia Agents; Antipsychotic Agents; Antiviral Agents; Humans; Iatrogenic Disea | 1999 |
Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Drug Evaluation; Female; Follow-Up Studies; Humans; H | 2001 |
[Paroxysmal atrial fibrillation in community medicine: management intentions and cost estimates].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Dis | 2001 |
[Iatrogenic thyroid pathology].
Topics: Amiodarone; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Diseases | 1977 |
'Low T3 syndrome' in patients chronically treated with an iodine-containing drug, amiodarone.
Topics: Amiodarone; Benzofurans; Humans; Iodine; Thyroid Diseases; Thyroxine; Triiodothyronine | 1978 |
[Amiodarone and thyroid function].
Topics: Amiodarone; Benzofurans; Coronary Disease; Thyroid Diseases | 1976 |
[Thyroid function in patients during long-term treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; | 1992 |
Long-term amiodarone therapy and antithyroid antibodies.
Topics: Adult; Amiodarone; Autoantibodies; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged | 1992 |
[Thyroid dysfunction induced by amiodarone in Catalonia. Prevalence and characteristics].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Child; Female; Humans; Male; Middle Aged; Pr | 1991 |
Changes in 127I mice thyroid follicle studied by analytical ion microscopy: a key for the comprehension of amiodarone-induced thyroid diseases.
Topics: Amiodarone; Animals; Cytoplasm; Diet; Female; Image Processing, Computer-Assisted; Iodine; Mice; Mic | 1990 |
Iodine induced thyroid disease.
Topics: Amiodarone; Female; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Iodine | 1990 |
[Dysthyroidism caused by amiodarone. Frequency and diagnosis].
Topics: Amiodarone; Humans; Hyperthyroidism; Hypothyroidism; Thyroid Diseases; Thyrotropin; Thyroxine; Triio | 1989 |
[The effect of amiodarone on thyroid gland activity].
Topics: Adult; Aged; Amiodarone; Female; Humans; Male; Middle Aged; Thyroid Diseases; Thyroid Gland | 1989 |
[Thyroid dis pre-existing or caused by amiodarone. A plea for a systematic hormone detection].
Topics: Amiodarone; Diagnosis, Differential; Humans; Thyroid Diseases; Thyrotropin | 1986 |
[Prevalence of dysthyroidism during treatment with amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Male; Middle Aged; Thyroid Diseases | 1988 |
[Adverse effects during chronic treatment with low-dose amiodarone].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Child; Drug Interactions; Eye Diseases; | 1985 |
Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patients.
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Immunoassay; | 1986 |
Amiodarone and the thyroid.
Topics: Amiodarone; Benzofurans; Humans; Thyroid Diseases; Thyroid Gland; Thyroid Hormones | 1986 |
Effect of amiodarone on circulating antithyroid antibodies.
Topics: Amiodarone; Autoantibodies; Female; Humans; Male; Thyroid Diseases; Thyroid Gland | 1988 |
Side effects and complications of amiodarone therapy.
Topics: Amiodarone; Arrhythmias, Cardiac; Ataxia; Benzofurans; Drug Eruptions; Drug Interactions; Female; Ga | 1985 |
Anti-amiodarone antibodies: detection and relationship to the development of side effects.
Topics: Adult; Aged; Amiodarone; Antibodies; Arrhythmias, Cardiac; Female; Humans; Immunoassay; Male; Middle | 1988 |
Amiodarone and thyroid autoimmunity in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Autoantibodies; Female; Humans; Male; Middle Aged; Prosp | 1988 |
Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone.
Topics: Amiodarone; Autoantibodies; Female; Humans; Male; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; | 1988 |
Diagnosis of amiodarone-iodine-induced thyrotoxicosis(AIIT) associated with severe nonthyroidal illness.
Topics: Aged; Amiodarone; Diagnosis, Differential; Humans; Hyperthyroidism; Iodine; Male; Sex Hormone-Bindin | 1987 |
Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset.
Topics: Adult; Aged; Amiodarone; Antibodies, Monoclonal; Autoantibodies; Autoimmune Diseases; Benzofurans; F | 1986 |
Effects of amiodarone during pregnancy.
Topics: Adult; Amiodarone; Female; Heart Ventricles; Humans; Infant, Newborn; Iodine; Maternal-Fetal Exchang | 1987 |
Risk factors for development of amiodarone-induced thyroid dysfunction.
Topics: Amiodarone; Humans; Risk; Thyroid Diseases | 1987 |
Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Autoantibodies; Female; Follow-Up Studies; Humans; Hypot | 1987 |
Effects of amiodarone and thyroid dysfunction on myocardial calcium, serum calcium and thyroid hormones in the rat.
Topics: Amiodarone; Animals; Calcium; Hypothyroidism; In Vitro Techniques; Male; Muscle Proteins; Myocardium | 1987 |
Amiodarone and thyroid hormone metabolism.
Topics: Amiodarone; Angina Pectoris; Female; Humans; Hypothyroidism; Iodine; Male; Thyroid Diseases; Thyroid | 1986 |
Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Thyroid Diseases; Thyroid Funct | 1986 |
[Thyroid, amiodarone and autoimmunity].
Topics: Amiodarone; Autoantibodies; Humans; Middle Aged; Thyroid Diseases | 1986 |
[Hyper and hypothyroidism induced by amiodarone].
Topics: Adult; Amiodarone; Female; Humans; Hyperthyroidism; Hypothyroidism; Imidazoles; Male; Middle Aged; P | 1986 |
Amiodarone-induced thyroid gland dysfunction.
Topics: Amiodarone; Female; Humans; Hypothyroidism; Iodine; Male; Tachycardia; Thyroid Diseases; Thyroid Gla | 1987 |
[Incidence of thyroid dysfunction in patients during chronic treatment with amiodarone].
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Male; Middle Aged; Thyroid Diseases; Thyroid F | 1985 |
[Recent advances in thyroid pathology in Chile].
Topics: Adult; Amiodarone; Chile; Female; Humans; Iodine; Iodine Radioisotopes; Male; Middle Aged; Thyroid D | 1985 |
Amiodarone and the thyroid.
Topics: Amiodarone; Benzofurans; Humans; Thyroid Diseases; Thyroid Hormones | 1985 |
[Amiodarone and the thyroid].
Topics: Amiodarone; Benzofurans; Humans; Iodine; Thyroid Diseases; Thyroid Gland; Thyroid Hormones; Triiodot | 1985 |
Amiodarone and antithyroid antibodies.
Topics: Amiodarone; Autoantibodies; Benzofurans; Humans; Retrospective Studies; Thyroid Diseases; Thyroid Gl | 1985 |
[Thyroid pathology iatrogenically induced by iodinated products].
Topics: Amiodarone; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Thyroid Diseases; Thyroid Hormo | 1985 |
[Hyper- or hypothyroidism in chronic treatment with amiodarone: a diagnostic and therapeutic dilemma].
Topics: Adult; Aged; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Hypothyroidism; Male; Middle | 1985 |